2013China Foreign Medical TreatmentRequires access

Difference of clinical efficacy of topiramate and carbamazepine in the treatment of cerebral infarction with secondary epilepsy

Huang Bingwen

Open publisher page 0 citations

Abstract

Objective To explore the difference of clinical efficacy of topiramate and carbamazepine in the treatment of cerebral infarction with secondary epilepsy. Methods 60 cases with epilepsy after cerebral infarction were selected from april 2010 to april,2012. and they were randomly divided into observation group and control group. topiramate was given to observation group. the course was 24 weeks. after 24 weeks,clinical efficacy was evaluated in two groups. Results The total effective rate in the observation group was 96.7%,the total effective rate in the control group was 70.0%,the total effective rate in the observation group compared with that in control group,the total effective rate in the observation group was higher than that in control group,the difference was statistically significant(P0.05). Conclusion Topiramate in treatment of cerebral infarction with secondary epilepsy has significantly clinical efficacy,and which is superior to carbamazepine.

About this research paper

What this paper is about

Objective To explore the difference of clinical efficacy of topiramate and carbamazepine in the treatment of cerebral infarction with secondary epilepsy. Methods 60 cases with epilepsy after cerebral infarction were selected from april 2010 to april,2012. and they were randomly divided into observation group and control group. topiramate was given to observation group. the course was 24 weeks. after 24 weeks,clinical efficacy was evaluated in two groups. Results The total effective rate in the observation group was 96.7%,the total effective rate in the control group was 70.0%,the total effective rate in the observation group compared with that in control group,the total effective rate in the observation group was higher than that in control group,the difference was statistically significant(P0.05). Conclusion Topiramate in treatment of cerebral infarction with secondary epilepsy has significantly clinical efficacy,and which is superior to carbamazepine.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the difference of clinical efficacy of topiramate and carbamazepine in the treatment of cerebral infarction with secondary epilepsy. Methods 60 cases with epilepsy after cerebral infarction were selected from april 2010 to april,2012. and they were randomly divided into observation group and control group. topiramate was given to observation group. the course was 24 weeks. after 24 weeks,clinical efficacy was evaluated in two groups. Results The total effective rate in the observation group was 96.7%,the total effective rate in the control group was 70.0%,the total effective rate in the observation group compared with that in control group,the total effective rate in the observation group was higher than that in control group,the difference was statistically significant(P0.05). Conclusion Topiramate in treatment of cerebral infarction with secondary epilepsy has significantly clinical efficacy,and which is superior to carbamazepine.

Key concepts: Topiramate, Medicine, Carbamazepine, Epilepsy, Clinical efficacy, Anesthesia, Cerebral infarction, Significant difference

Related papers

Back to paper searchBrowse research topicsOriginal source
Difference of clinical efficacy of topiramate and carbamazepine in the treatment of cerebral infarction with secondary epilepsy — Research Paper | ScholarLens